News
ERNAW
0.0620
0.00%
0.0000
Ernexa Therapeutics SVP of Finance Sandra Gurrola resigns effective July 3
PUBT · 29m ago
Ernexa expects FDA review of ERNA-101 IND in Q4 2026
PUBT · 06/17 13:27
ERNEXA THERAPEUTICS - PLANS IND SUBMISSION FOR ERNA-101 IN Q3 2026 AND PHASE 1 STUDY IN Q4 2026
Reuters · 06/17 12:48
Ernexa Therapeutics announces annual shareholder meeting
PUBT · 05/11 21:11
Ernexa Q1 net loss narrows 32.87% to $5.51 million; no revenue
PUBT · 05/11 21:03
Ernexa Therapeutics to join Virtual Investor Closing Bell event
PUBT · 05/11 13:16
BUZZ-U.S. STOCKS ON THE MOVE-Instacart, New York Times, Novavax
Reuters · 05/06 17:51
Ernexa reports ERNA-101 plus PD-1 blockade clears tumors in ovarian cancer models
PUBT · 05/06 12:33
Ernexa Therapeutics announces 1-for-25 reverse stock split to regain Nasdaq compliance
Seeking Alpha · 04/30 13:11
ERNEXA THERAPEUTICS ANNOUNCES 1-FOR-25 REVERSE STOCK SPLIT
Reuters · 04/30 13:00
Ernexa Therapeutics authorizes 1-for-10 to 1-for-25 reverse stock split to meet Nasdaq bid rule
PUBT · 04/13 13:29
Ernexa Therapeutics files draft information statement for potential reverse stock split
Reuters · 04/01 21:23
Ernexa targets Q4 2026 start for ERNA-101 Phase 1 ovarian cancer trial
Reuters · 03/31 21:39
Ernexa Therapeutics faces Nasdaq delisting notice after bid price falls below $1 for 30 days
Reuters · 03/20 21:01
ERNEXA THERAPEUTICS INC - MAY OFFER UP TO $50 MLN OF SECURITIES - SEC FILING
Reuters · 03/16 10:01
Ernexa Therapeutics FY 2025 net loss narrows 68% to USD 14.08 million
Reuters · 03/13 21:23
Ernexa Therapeutics CEO Sanjeev Luther to Join Virtual Investor Closing Bell Series Webcast
Reuters · 02/20 14:05
Ernexa Therapeutics Announces Issuance of Warrants in $10.5 Million Public Offering
Reuters · 02/11 22:11
Ernexa Therapeutics Announces $10.5 Million Offering With Warrants to Purchase 21 Million Shares
Reuters · 02/06 14:25
ERNEXA THERAPEUTICS ANNOUNCES PRICING OF $10.5 MILLION PUBLIC OFFERING
Reuters · 02/06 14:25
More
Webull provides a variety of real-time ERNAW stock news. You can receive the latest news about Ernexa Therapeutics Inc through multiple platforms. This information may help you make smarter investment decisions.